Guggenheim Maintains Buy on Pharvaris, Raises Price Target to $40

Pharvaris N.V.

Pharvaris N.V.

PHVS

0.00

Guggenheim analyst Debjit Chattopadhyay maintains Pharvaris (NASDAQ: PHVS) with a Buy and raises the price target from $39 to $40.